Brief Biography

Dr. Sarah Alexander is a clinician-teacher in the Division of Haematology/ Oncology at The Hospital for Sick Children. Sarah attended medical school at Harvard University. She did her paediatric training at the Children's Hospital, Boston, and her fellowship in Haematology and Oncology at Children's Hospital, Boston and the Dana Farber Cancer Institute. 

After the completion of training she remained on staff at the Dana Farber Cancer Institute before moving to the Division of Paediatric Haematology and Oncology at Rainbow Babies and Children’s Hospital in Cleveland, where she was the director of the inpatient Haematology/Oncology ward and the fellowship training program. 

Sarah’s areas of interest include Leukemia, non Hodgkins Lymphoma, infectious complications of cancer therapy and medical education.

Publications

Tetzlaff W., Alexander S.W., Miller F.D. and Bisby M.A: Response of facial and rubrospinal neurons to axotomy: Changes in mRNA expression for cytoskeletal proteins and GAP-43. Journal of Neurosciences 1991: 11(8): pp 2528-2544.

Parsons S.K., Mayer D.K., Alexander S.W., Xu R., Land V., and Laver J: Growth factor practice patterns among paediatric oncologists: Results of a 1998 Paediatric Oncology Group Survey. Economic Evaluation Working Group the Paediatric Oncology Group. Journal of Paediatric Haematology Oncology 2000: 22(3): pp 227-241.

Alexander S.W., Wade K.C., Hibberd P., and Parsons S.K: Evaluation of risk prediction criteria for episodes of febrile neutropenia in paediatric cancer patients. Journal of Paediatric Haematology Oncology 2002: 24(1): pp 38-42.

Feldmann J., LeDiest F., Ouachee-Chardin M., Certain S., Alexander S.W., Quartier P., Haddad E., Wulffraat N., Casanova J.L., Blanche S., Fischer A., and de Saint Basile G: Functional consequences of perforin gene mutation in 22 patients with familial haemophagocytic lymphohistiocytosis. British Journal of Haematology 2002: 117(4): pp 965-972.

Fleming M.D., Alexander S.W., Fournier M.V., Sallan S.E., Nichols K., Carpintieri D., and Rollins B.J: Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis. Blood 2003: 101(7): pp 2473-2475.

Palmert M.R., Alexander S.W., and Goorin A.M: Ovarin toxicity after chemotherapy: Possible association with ifosfamide administration. Pediatric Blood and Cancer 2004: 42(3): pp 219-219.

Shah M.D., O'Riordan M.A., and Alexander S.W: Evaluation of Prolonged aPTT Values in the Paediatric Population. Clinical Paediatrics 2006: 45(4): pp 347-353.

Alexander S.W., Hopewell S., Hunter S., and Chouksey A: Rituximab and desensitization for a patient with severe factor IX deficiency, inhibitors and history of anaphylaxis. Journal of Paediatric Haematology Oncology 2008: 30(1): pp 93-95.

Li X. and Alexander S.W: Herediatry Persistance of Alpha-Fetoprotein. Pediatric Blood and Cancer 2009: 52(3): pp 403-5.

Lusher J, Pipe S, Alexander S, Nugent D. Prophylactic therapy with Fibrogammin P is associated with a decreased incidence of bleeding episodes: a retrospective study. Haemophilia 2010: 16(2): pp 316-321.

Sung L, Yanofsky R, Klaasen RJ, Dix D, Pritchard S, Winick N, Alexander S, Klassen A. Quality of life during active treatment for pedauitrc acute lymphoblastic leukemia. Int J Cancer 2010, May 4, epub.